Skip to content
10-K

Annual Report

Arena Pharmaceuticals, Inc.

0001564590-21-007609

← back to feed
Filed
Feb 23, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Feb 18, 2021 60.33M sh
Eps Diluted FY 2019 · Dec 31, 2020 −$2.10
Eps Diluted FY 2019 · Sep 30, 2020 −$1.69
Eps Diluted FY 2019 · Jun 30, 2020 −$1.61
Eps Diluted FY 2019 · Mar 31, 2020 −$2.00
Eps Diluted FY 2019 · Dec 31, 2019 −$1.76
Eps Diluted FY 2019 · Sep 30, 2019 −$1.46
Eps Diluted FY 2019 · Jun 30, 2019 −$1.24
Eps Diluted FY 2019 · Mar 31, 2019 $12.10
Eps Diluted FY 2019 · Dec 31, 2018 −$0.63
Eps Basic FY 2019 · Dec 31, 2020 −$2.10
Eps Basic FY 2019 · Sep 30, 2020 −$1.69
Eps Basic FY 2019 · Jun 30, 2020 −$1.61
Eps Basic FY 2019 · Mar 31, 2020 −$2.00
Eps Basic FY 2019 · Dec 31, 2019 −$1.76
Eps Basic FY 2019 · Sep 30, 2019 −$1.46
Eps Basic FY 2019 · Jun 30, 2019 −$1.24
Eps Basic FY 2019 · Mar 31, 2019 $12.53
Eps Basic FY 2019 · Dec 31, 2018 −$0.63
Rd Expense FY 2019 · Dec 31, 2020 $323.74M
Rd Expense FY 2019 · Dec 31, 2019 $231.5M
Rd Expense FY 2019 · Dec 31, 2018 $115.03M
Cash And Equivalents FY 2019 · Dec 31, 2019 $243.27M
Current Liabilities FY 2019 · Dec 31, 2019 $44.97M
Current Assets FY 2019 · Dec 31, 2019 $759.93M
Total Assets FY 2019 · Dec 31, 2019 $1.17B
Shares Diluted restated FY 2019 · Dec 31, 2018 47.04K sh
Capex FY 2019 · Dec 31, 2018 $692K
Operating Cash Flow FY 2019 · Dec 31, 2018 −$132.21M
Sga Expense FY 2019 · Dec 31, 2018 $45.26M
Net Income FY 2019 · Dec 31, 2018 −$29.4M
Operating Income FY 2019 · Dec 31, 2018 −$144.78M
Revenue FY 2019 · Dec 31, 2018 $17.97M